{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "8213343", "DateCompleted": {"Year": "1993", "Month": "11", "Day": "05"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "25"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0065-4299", "JournalIssue": {"Volume": "38", "Issue": "3-4", "PubDate": {"Year": "1993", "Month": "Mar"}}, "Title": "Agents and actions", "ISOAbbreviation": "Agents Actions"}, "ArticleTitle": "A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.", "Pagination": {"StartPage": "171", "EndPage": "177", "MedlinePgn": "171-7"}, "Abstract": {"AbstractText": ["Airway hyperresponsiveness is a key feature of asthma, and attenuating airway hyperresponsiveness is an important part of asthma therapy. In the present study we examined the inhibitory effect of a potent 5-lipoxygenase inhibitor, FR110302, on airway hyperresponsiveness induced by ozone exposure in guinea pigs and dogs. Respiratory resistance (Rrs) was measured by a forced oscillation method. Airway responsiveness was determined from the dose-response curve of Rrs to acetylcholine. Guinea pigs were exposed to 2.5 ppm ozone for 1 h. In a control group of guinea pigs, delta log PC100 (the index of the ozone-induced airway hyperresponsiveness) was 0.58 +/- 0.04 (log mg/ml). Treatment with FR110302 (10 or 100 mg/kg p.o.) significantly diminished delta log PC100 (10 mg/kg: 0.22 +/- 0.10; 100 mg/kg; 0.11 +/- 0.06). Dogs were exposed to 3 ppm ozone for 2 h. In a control group of dogs, delta log Dmin (another index of the ozone-induced airway hyperresponsiveness) was 1.24 +/- 0.15 (log unit). Treatment with FR110302 (1 or 3.2 mg/kg p.o.) significantly diminished delta log Dmin (1 mg/kg: 0.60 +/- 0.18; 3.2 mg/kg: 0.27 +/- 0.12). These results suggest that FR110302 may be a useful drug for attenuating airway hyperresponsiveness in asthmatic patients."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Tsukuba Research Laboratories, Ibaraki, Japan."}], "Identifier": [], "LastName": "Asano", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Imai", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Inoue", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Masunaga", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Inamura", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yatabe", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hiroi", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nakahara", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Notsu", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Takishima", "ForeName": "T", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Agents Actions", "NlmUniqueID": "0213341", "ISSNLinking": "0065-4299"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Lipoxygenase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthols"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolines"}, {"RegistryNumber": "119256-94-9", "NameOfSubstance": "FR 110302"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Acetylcholine"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": ["drug effects"], "DescriptorName": "Airway Resistance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Lipoxygenase Inhibitors"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Naphthols"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Quinolines"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Am Rev Respir Dis. 1984 Aug;130(2):214-9", "ArticleIdList": ["6465675"]}, {"Citation": "Eur J Pharmacol. 1990 Aug 2;184(1):87-95", "ArticleIdList": ["2170151"]}, {"Citation": "Prostaglandins. 1985 Oct;30(4):563-72", "ArticleIdList": ["3909232"]}, {"Citation": "Allergy. 1986 Jul;41(5):365-72", "ArticleIdList": ["3021017"]}, {"Citation": "Am Rev Respir Dis. 1986 Aug;134(2):258-61", "ArticleIdList": ["3509981"]}, {"Citation": "Am Rev Respir Dis. 1983 Jun;127(6):686-90", "ArticleIdList": ["6859651"]}, {"Citation": "J Allergy Clin Immunol. 1985 Aug;76(2 Pt 1):162-6", "ArticleIdList": ["3926851"]}, {"Citation": "Am Rev Respir Dis. 1986 Jun;133(6):1127-32", "ArticleIdList": ["3521417"]}, {"Citation": "Thorax. 1984 Jul;39(7):500-4", "ArticleIdList": ["6463929"]}, {"Citation": "J Appl Physiol (1985). 1985 Dec;59(6):1941-6", "ArticleIdList": ["3001017"]}, {"Citation": "Int Arch Allergy Appl Immunol. 1986;81(4):363-7", "ArticleIdList": ["2430895"]}, {"Citation": "Am Rev Respir Dis. 1985 Nov;132(5):1005-9", "ArticleIdList": ["3933389"]}, {"Citation": "Arerugi. 1989 Jul;38(7):532-41", "ArticleIdList": ["2510702"]}, {"Citation": "Agents Actions. 1992 Jul;36(3-4):215-21", "ArticleIdList": ["1382375"]}, {"Citation": "Chest. 1981 Nov;80(5):600-6", "ArticleIdList": ["7297152"]}, {"Citation": "J Appl Physiol (1985). 1985 Apr;58(4):1347-53", "ArticleIdList": ["3988688"]}, {"Citation": "J Appl Physiol (1985). 1985 Dec;59(6):1918-23", "ArticleIdList": ["3935642"]}, {"Citation": "Am Rev Respir Dis. 1990 Jul;142(1):133-7", "ArticleIdList": ["2114809"]}, {"Citation": "Am Rev Respir Dis. 1987 Oct;136(4):922-9", "ArticleIdList": ["3662243"]}, {"Citation": "J Appl Physiol (1985). 1986 Sep;61(3):864-72", "ArticleIdList": ["3093455"]}, {"Citation": "Am Rev Respir Dis. 1985 Mar;131(3):314-20", "ArticleIdList": ["3977170"]}, {"Citation": "Biochem Biophys Res Commun. 1983 Aug 12;114(3):1071-6", "ArticleIdList": ["6311194"]}, {"Citation": "J Allergy Clin Immunol. 1989 Jun;83(6):1013-26", "ArticleIdList": ["2659643"]}, {"Citation": "Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Feb;28(2):293-9", "ArticleIdList": ["2162445"]}, {"Citation": "Prostaglandins. 1982 Sep;24(3):419-32", "ArticleIdList": ["6818617"]}, {"Citation": "Am Rev Respir Dis. 1984 Aug;130(2):220-4", "ArticleIdList": ["6465676"]}, {"Citation": "J Appl Physiol. 1970 May;28(5):675-8", "ArticleIdList": ["5445392"]}, {"Citation": "Am Rev Respir Dis. 1992 Jun;145(6):1270-4", "ArticleIdList": ["1595990"]}]}], "History": [{"Year": "1993", "Month": "3", "Day": "1"}, {"Year": "1993", "Month": "3", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1993", "Month": "3", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8213343", "10.1007/BF01976208"]}}], "PubmedBookArticle": []}